| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 15,024,577 | 18,485,718 | 15,359,744 | | Cost of Revenue | 5,147,770 |
-
| 3,665,053 | | | Gross Profit | 9,876,806 | 18,485,718 | 11,694,691 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,916,741 | 5,186,161 | 4,514,438 | | Non Recurring | 875 |
-
|
-
| | Others | 2,189,810 | 480,982 | 240,712 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,769,380 | 12,818,575 | 6,939,541 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,769,380 | 12,818,575 | 6,939,541 | | Interest Expense | 2,339,952 | 7,356,193 | 2,079,431 | | Income Before Tax | 1,429,428 | 5,462,382 | 4,860,110 | | Income Tax Expense | 363,078 | 1,327,076 | 1,530,004 | | Minority Interest | (5,579) | (4,688) | (5,103) | | | | Net Income From Continuing Ops | 1,060,771 | 4,130,618 | 3,325,003 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (1,814) | | Other Items |
-
|
-
|
-
| | | | Net Income | 1,060,771 | 4,130,618 | 3,323,189 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,060,771 | $4,130,618 | $3,323,189 |
|
0.22% Nasdaq 
Income Statement
